Bone tissue formation with human mesenchymal stem cells and biphasic calcium phosphate ceramics: The local implication of osteoclasts and macrophages

Biomaterials

Volumn 35, Issue 36, 2014, Pages 9660-9667

  Gamblin, Anne Laure ^a,b   Brennan, Meadhbh A ^a,b   Renaud, Audrey ^a,b   Yagita, Hideo ^c   Lézot, Frédéric ^a,b,d   Heymann, Dominique ^a,b,d,e   Trichet, Valérie ^a,b,d   Layrolle, Pierre ^a,b  

^a INSERM   (France)

^b UNIVERSITÉ DE NANTES   (France)

^c JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d Equipe LIGUE Nationale Contre le Cancer 2012   (France)

^e HÔTEL DIEU   (France)

Author keywords

Foreign body reaction; MAb anti RANKL; Macrophages; Osteoclasts; Osteoinduction

Indexed keywords

BONE; CALCIUM PHOSPHATE; CELL CULTURE; CERAMIC MATERIALS; GENE EXPRESSION; MACROPHAGES; TISSUE;

BIPHASIC CALCIUM PHOSPHATES; BONE TISSUE FORMATION; FOREIGN BODY REACTIONS; HAEMATOPOIETIC STEM CELLS; HUMAN MESENCHYMAL STEM CELLS; MAB ANTI-RANKL; OSTEOCLASTS; OSTEOINDUCTION;

STEM CELLS;

OSTEOCLAST DIFFERENTIATION FACTOR; CERAMICS; HYDROXYAPATITE; HYDROXYAPATITE-BETA TRICALCIUM PHOSPHATE; MONOCLONAL ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE DEVELOPMENT; BONE TISSUE; CALCIUM PHOSPHATE CERAMIC; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; MACROPHAGE; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; MOUSE; NONHUMAN; OSSIFICATION; OSTEOCLAST; OSTEOCLAST ACTIVITY; OSTEOCLASTOGENESIS; PRIORITY JOURNAL; STEM CELL MOBILIZATION; ADVERSE EFFECTS; ANIMAL; ANTAGONISTS AND INHIBITORS; CELL CULTURE; CELL DIFFERENTIATION; CERAMICS; CYTOLOGY; DRUG EFFECTS; FOREIGN BODIES; MESENCHYMAL STROMA CELL; NUDE MOUSE; PHARMACOLOGY; PROSTHESES AND ORTHOSES;

MUS MUSCULUS;

ANIMALS; ANTIBODIES, MONOCLONAL; CELL DIFFERENTIATION; CELLS, CULTURED; CERAMICS; FOREIGN BODIES; HUMANS; HYDROXYAPATITES; MACROPHAGES; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICE; MICE, NUDE; OSTEOCLASTS; OSTEOGENESIS; PROSTHESES AND IMPLANTS; RANK LIGAND;

EID: 84922360749     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2014.08.018     Document Type: Article

References (36)

1. Oryan A., Alidadi S., Moshiri A., Maffulli N. Bone regenerative medicine: classic options, novel strategies, and future directions. JOrthop Surg Res 2014, 9:18.
2. Choi H., Park N.-J., Jamiyandorj O., Hong M.-H., Oh S., Park Y.-B., et al. Improvement of osteogenic potential of biphasic calcium phosphate bone substitute coated with synthetic cell binding peptide sequences. JPeriodontal Implant Sci 2012, 42:166-172.
3. Nandi S.K., Roy S., Mukherjee P., Kundu B., De D.K., Basu D. Orthopaedic applications of bone graft & graft substitutes: a review. Indian J Med Res 2010, 132:15-30.
4. Garcia P., Franz D., Raschke M. Bone substitutes - basic principles and clinical applications. ZOrthop Unf 2014, 152:152-160.
5. Fekete N., Rojewski M.T., Fürst D., Kreja L., Ignatius A., Dausend J., et al. GMP-compliant isolation and large-scale expansion of bone marrow-derived MSC. PLoS ONE 2012, 7:e43255.
6. Cordonnier T., Langonné A., Corre P., Renaud A., Sensebé L., Rosset P., et al. Osteoblastic differentiation and potent osteogenicity of three-dimensional hBMSC-BCP particle constructs. JTissue Eng Regen Med 2014, 8:364-376.
7. Veronesi E., Murgia A., Caselli A., Grisendi G., Piccinno M.S., Rasini V., et al. Transportation conditions for prompt use of exvivo expanded and freshly harvested clinical-grade bone marrow mesenchymal stromal/stem cells for bone regeneration. Tissue Eng Part C Methods 2014, 20:239-251.
8. Tour G., Wendel M., Tcacencu I. Bone marrow stromal cells enhance the osteogenic properties of hydroxyapatite scaffolds by modulating the foreign body reaction. JTissue Eng Regen Med 2012, 10.1002/term.1574.
9. Le Blanc K., Mougiakakos D. Multipotent mesenchymal stromal cells and the innate immune system. Nat Rev Immunol 2012, 12:383-396.
10. Shin L., Peterson D.A. Human mesenchymal stem cell grafts enhance normal and impaired wound healing by recruiting existing endogenous tissue stem/progenitor cells. Stem Cells Transl Med 2013, 2:33-42.
11. Song G., Habibovic P., Bao C., Hu J., van Blitterswijk C.A., Yuan H., et al. The homing of bone marrow MSCs to non-osseous sites for ectopic bone formation induced by osteoinductive calcium phosphate. Biomaterials 2013, 34:2167-2176.
12. Grage-Griebenow E., Flad H.D., Ernst M. Heterogeneity of human peripheral blood monocyte subsets. JLeukoc Biol 2001, 69:11-20.
13. Adutler-Lieber S., Ben-Mordechai T., Naftali-Shani N., Asher E., Loberman D., Raanani E., et al. Human macrophage regulation via interaction with cardiac adipose tissue-derived mesenchymal stromal cells. JCardiovasc Pharmacol Ther 2013, 18:78-86.
14. Nakajima H., Uchida K., Guerrero A.R., Watanabe S., Sugita D., Takeura N., et al. Transplantation of mesenchymal stem cells promotes an alternative pathway of macrophage activation and functional recovery after spinal cord injury. JNeurotrauma 2012, 29:1614-1625.
15. Németh K., Leelahavanichkul A., Yuen P.S.T., Mayer B., Parmelee A., Doi K., et al. Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production. Nat Med 2009, 15:42-49.
16. Alexander K.A., Chang M.K., Maylin E.R., Kohler T., Müller R., Wu A.C., et al. Osteal macrophages promote invivo intramembranous bone healing in a mouse tibial injury model. JBone Min Res 2011, 26:1517-1532.
17. Kreja L., Brenner R.E., Tautzenberger A., Liedert A., Friemert B., Ehrnthaller C., et al. Non-resorbing osteoclasts induce migration and osteogenic differentiation of mesenchymal stem cells. JCell Biochem 2010, 109:347-355.
18. Pederson L., Ruan M., Westendorf J.J., Khosla S., Oursler M.J. Regulation of bone formation by osteoclasts involves Wnt/BMP signaling and the chemokine sphingosine-1-phosphate. Proc Natl Acad Sci U S A 2008, 105:20764-20769.
19. Davison N.L., Gamblin A.-L., Layrolle P., Yuan H., de Bruijn J.D., Barrère-de Groot F. Liposomal clodronate inhibition of osteoclastogenesis and osteoinduction by submicrostructured beta-tricalcium phosphate. Biomaterials 2014, 35:5088-5097.
20. Kamijo S., Nakajima A., Ikeda K., Aoki K., Ohya K., Akiba H., et al. Amelioration of bone loss in collagen-induced arthritis by neutralizing anti-RANKL monoclonal antibody. Biochem Biophys Res Commun 2006, 347:124-132.
21. Redaelli S., Bentivegna A., Foudah D., Miloso M., Redondo J., Riva G., et al. From cytogenomic to epigenomic profiles: monitoring the biologic behavior of invitro cultured human bone marrow mesenchymal stem cells. Stem Cell Res Ther 2012, 3:47.
22. Li Q., Yu Y., Bischoff J., Mulliken J.B., Olsen B.R. Differential expression of CD146 in tissues and endothelial cells derived from infantile haemangioma and normal human skin. JPathol 2003, 201:296-302.
23. Knowles R.G., Moncada S. Nitric oxide synthases in mammals. Biochem J 1994, 298(Pt 2):249-258.
24. He L.-Z., Crocker A., Lee J., Mendoza-Ramirez J., Wang X.-T., Vitale L.A., et al. Antigenic targeting of the human mannose receptor induces tumor immunity. JImmunol 2007, 178:6259-6267.
25. Becquart P., Cambon-Binder A., Monfoulet L.-E., Bourguignon M., Vandamme K., Bensidhoum M., et al. Ischemia is the prime but not the only cause of human multipotent stromal cell death in tissue-engineered constructs invivo. Tissue Eng Part A 2012, 18:2084-2094.
26. Deschepper M., Manassero M., Oudina K., Paquet J., Monfoulet L.-E., Bensidhoum M., et al. Proangiogenic and prosurvival functions of glucose in human mesenchymal stem cells upon transplantation. Stem Cells 2013, 31:526-535.
27. Tasso R., Augello A., Boccardo S., Salvi S., Caridà M., Postiglione F., et al. Recruitment of a host's osteoprogenitor cells using exogenous mesenchymal stem cells seeded on porous ceramic. Tissue Eng Part A 2009, 15:2203-2212.
28. Beuvelot J., Pascaretti-Grizon F., Filmon R., Moreau M.-F., Baslé M.F., Chappard D. Invitro assessment of osteoblast and macrophage mobility in presence of β-TCP particles by videomicroscopy. JBiomed Mater Res A 2011, 96:108-115.
29. Velard F., Laurent-Maquin D., Braux J., Guillaume C., Bouthors S., Jallot E., et al. The effect of zinc on hydroxyapatite-mediated activation of human polymorphonuclear neutrophils and bone implant-associated acute inflammation. Biomaterials 2010, 31:2001-2009.
30. Roh J.D., Sawh-Martinez R., Brennan M.P., Jay S.M., Devine L., Rao D.A., et al. Tissue-engineered vascular grafts transform into mature blood vessels via an inflammation-mediated process of vascular remodeling. Proc Natl Acad Sci U S A 2010, 107:4669-4674.
31. Fernandes T.J., Hodge J.M., Singh P.P., Eeles D.G., Collier F.M., Holten I., et al. Cord blood-derived macrophage-lineage cells rapidly stimulate osteoblastic maturation in mesenchymal stem cells in a glycoprotein-130 dependent manner. PLoS ONE 2013, 8:e73266.
32. Guihard P., Danger Y., Brounais B., David E., Brion R., Delecrin J., et al. Induction of osteogenesis in mesenchymal stem cells by activated monocytes/macrophages depends on oncostatin M signaling. Stem Cells 2012, 30:762-772.
33. Maggini J., Mirkin G., Bognanni I., Holmberg J., Piazzón I.M., Nepomnaschy I., et al. Mouse bone marrow-derived mesenchymal stromal cells turn activated macrophages into a regulatory-like profile. PLoS ONE 2010, 5:e9252.
34. Cho D.-I., Kim M.R., Jeong H., Jeong H.C., Jeong M.H., Yoon S.H., et al. Mesenchymal stem cells reciprocally regulate the M1/M2 balance in mouse bone marrow-derived macrophages. Exp Mol Med 2014, 46:e70.
35. Eirin A., Zhu X.-Y., Li Z., Ebrahimi B., Zhang X., Tang H., et al. Endothelial outgrowth cells shift macrophage phenotype and improve kidney viability in swine renal artery stenosis. Arterioscler Thromb Vasc Biol 2013, 33:1006-1013.
36. Bouvet-Gerbettaz S., Boukhechba F., Balaguer T., Schmid-Antomarchi H., Michiels J.-F., Scimeca J.-C., et al. Adaptive immune response inhibits ectopic mature bone formation induced by BMSCs/BCP/plasma composite in immune-competent mice. Tissue Eng Part A 2014, [in press].